Finance

Beta
Lists
RAPH:OTCMKTS
Raphael Pharmaceutical Inc
$1.40
0.00%
(0.00) 1D
Apr 29, 9:34:17 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RAPH...
Mkt. cap
28.25M
Avg. vol.
12.00
Volume
0.00
52-wk high
$1.40
52-wk low
$0.04
EPS
-$0.05
Beta
0.28
Shares outstanding
20.18M
No. of employees
0
Mkt. cap
28.25M
Avg. vol.
12.00
Volume
0.00
52-wk high
$1.40
52-wk low
$0.04
EPS
-$0.05
Beta
0.28
Shares outstanding
20.18M
No. of employees
0
News stories
From sources across the web
About Raphael Pharmaceutical Inc
CEO-
Employees0
Founded2007
Headquarters-
SectorBiotechnology
Websiteraphaelpharmaceutical.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
141.00K
73.00K
345.00K
37.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
174.00K
178.00K
-91.00K
186.00K
Operating expense
315.00K
251.00K
254.00K
223.00K
Total operating expenses
315.00K
251.00K
254.00K
223.00K
Operating income
-315.00K
-251.00K
-254.00K
-223.00K
Other non operating income
-
-
-1.00K
-
EBT including unusual items
-322.00K
-255.00K
-273.00K
-229.00K
EBT excluding unusual items
-322.00K
-255.00K
-273.00K
-229.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-322.00K
-255.00K
-273.00K
-229.00K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-7.00K
-4.00K
-2.00K
-6.00K
Net interest expenses
-7.00K
-4.00K
-2.00K
-6.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer